Defective aggregation in cirrhosis is independent of in vivo platelet activation

Journal of Hepatology

Volumn 24, Issue 4, 1996, Pages 436-443

  Laffi, Giacomo ^a,d   Cinotti, Sandro ^b   Filimberti, Ermino ^b   Ciabattoni, Giovanni ^c   Caporale, Roberto ^b   Marra, Fabio ^a   Melani, Lorenzo ^a   Grossi, Alberto ^b   Carloni, Vinicio ^a   Gentilini, Paolo ^a  

^a Istituto di Medicina Interna   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Dipartimento di Medicina Interna   (Italy)

Author keywords

11 deoxydro TXB2; 2,3 Dinor TXB2; Cirrhosis; Flow cyotmetry; GMP 140; GP 53; Platelet aggregation; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; 2,3 DINORTHROMBOXANE B2; BETA THROMBOGLOBULIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; LIVER CIRRHOSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; URINARY EXCRETION;

EID: 0029932775     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80164-4     Document Type: Article

References (47)

1. Kelly DA, Tuddenham EGD. Hemostatic problems in liver disease. Gut 1986; 27: 339-49.
2. Thomas DP, Ream VJ, Stuart RK. Platelet aggregation in patients with Laennec's cirrhosis of the liver. N Engl J Med 1967; 276: 1344-8.
3. Ballard HS, Marcus AJ. Platelet aggregation in portal cirrhosis. Arch Intern Med 1976; 136: 316-9.
4. Huijgens PC, Verhulst JC, Thijs LG. Platelet aggregation and portal cirrhosis (Letter). Arch Intern Med 1977; 137: 257.
5. Rubin MH, Weston MJ, Langley PG, White Y, Williams R. Platelet function in chronic liver disease. Relationship to disease severity. Dig Dis Sci 1979; 24: 197-202.
6. Owen JS, Hutton RA, Day RC, Bruckdorfer KR, McIntyre N. Platelet lipid composition and platelet aggregation in human liver disease. J Lipid Res 1981; 22: 423-430.
7. Ingeberg S, Jacobsen P, Fisher E, Bensten KD. Platelet aggregation and release of ATP in patients with hepatic cirrhosis. Scand J Gastroenterol 1985; 20: 285-8.
8. Laffi G, Cominelli F, Ruggiero M, Fedi S, Chiarugi VP, La Villa G, Pinzani M, Gentilini P. Altered platelet function in cirrhosis of liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists. Hepatology 1986; 6: 1620-6.
9. Desai K, Mistry P, Bagget C, Burroughs AK, Bellamy MF, Owen JS. Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis. Lancet 1989; i: 693-695.
10. Pareti FI, Capitanio A, Mannucci L, Ponticelli C, Mannucci PM. Acquired dysfunction due to the circulation of "exhausted" platelets. Am J Med 1980; 69: 235-40.
11. Martinez J, Palascak J.E. Hemostatic alterations in liver disease. In: Zakim D, Boyer T, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: W.B. Saunders Company, 1982; 546-80.
12. Stein SF, Harker LA. Kinetic and functional studies of platelets, fibrinogen and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 1982; 99: 217-30.
13. Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni, Orlandi L, Selli ML, Nenci GG, Gentilini P. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992; 103: 641-6.
14. Metzelaar MJ, Sixma JJ, Nieuwenhuis HK. Detection of platelet activation using activation specific monoclonal antibodies. Blood Cells 1990; 16: 85-96.
15. Corash L. Measurement of platelet activation by fluorescence-activated flow cytometry. Blood Cells 1990; 160: 97-108.
16. Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467-73.
17. Santoro S, Eby CS Laboratory evaluation of hemostatic disorders. In: Hoffman R, Benz EJ jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds Hematology: Basic Principles and Practice. New York: Churchill Livingstone, 1995; 1622-32.
18. Dawes J. Radioimmunoassay of secreted platelet proteins In: MacIntyre DE, Gordon JL, eds. Platelets in Biology and Pathology III. Amsterdam: Elsevier Science, 1987; 493-524.
19. Roberts LJ II, Sweetman BJ, Oates JA. Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem 1981; 256: 8384-93.
20. Mielke CH. International Committee Comunications: measurement of the bleeding time. Thromb Haemost 1984; 52: 210-1.
21. Quick AJ. Standardization of the one stage prothrombin time. Thromb Diath Haemorrh 1972; 27: 179-80.
22. Proctor RR, Rapport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 212-9.
23. Clauss A. Gerinnungsphysiolgische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
24. Ronby P, Nguyen G, Scarabin PY, Samama M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes: biochemical and multicenter validation of a two site immunoasorbent assay. Thromb Haemost 1989; 61: 409-14.
25. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-6.
26. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with antibody against synthetic peptide.Thromb Haemost 1991; 65: 153-9.
27. Triplett AA, Brandt JT, Mc Gann Batard MA, Dixon JLS, Fair DS. Hereditary factor VII deficiency: heterogenicity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-7.
28. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP Whitaker AN, Elms M, Bunce I, Webber AJ. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-78.
29. Bolton AE, Ludlac A, Moore S. Three approaches to radioimmunoassay of human beta-thromboglobulin. Br J Haematol 1976; 33: 233-8.
30. Ludlam CA, Cash ID Studies on liberation of beta-thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-47.
31. Morgenthaler JJ. Western blots of immune globulin preparations for intravenous use [Letter]. Transfusion 1987; 27: 369-70.
32. Chemielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-36.
33. Born GVL, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-95.
34. Young IT. Proof without prejudice: use of the Kolmorogov-Smirnov test for analysis of histograms from flow systems and other sources. Histochem Cytochem 1977; 25: 935-41.
35. Ciabattoni G, Maclouf J, Catella F, Fitzgerald GA, Patrono C. Radioimmunoassay of 11-dehydro-tnromboxane B2 in human plasma and urine. Biochim Biophys Acta 1987; 918: 293-97.
36. 2 in man. Biochim Biophys Acta 1989; 992: 66-70.
37. Patrono C, Ciabattoni G, Pugliese F, Pierucci A, Blair IA, Fitzgerald GA. Estimated rate of thromboxane secretion into the circulation of normal humans J Clin Invest 1986; 77: 590-4.
38. Laffi G, Marra F, Failli P, Ruggiero M, Cecchi E, Carloni V, Giotti A, Gentilini P. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology 1993; 105: 148-56.
39. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-12.
40. Vejar M, Fragasso G, Hackett D, Lipkin DP, Maseri A, Born GVR. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 1990; 63: 163-8.
41. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990; 322: 1769-74.
42. Landolfi R, Ciabattoni G, Patrignani P, Castellana MAL, Pogliani E, Bizzi B, Patrono C. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood 1992: 80: 1965-71.
43. Koustaal PJ, Ciabattoni G., Van Gijn J, Nieuwenhuis HK, De Groot P, Sixma J, Patrono C. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke 1993; 24: 219-23.
44. Van Kooten F, Ciabattoni G, Patrono C, Schmitz P, Van Gijn J, Koudstaal P Evidence for episodic platelet activation in acute ischemic stroke. Stroke 1994; 25: 278-81.
45. Kimmel M, Grossi A, Amuasi J, Vannucchi AM. Non parametric analysis of platelet lifespan. Cell Tissue Kinet 1990; 23: 191-202.
46. Kamisasa I, Hidai K, Sugiura M, Wada T, Yamanaka M. Effects of splenectomy on blood coagulation and fibrinolysis with liver cirrhosis: possible role of the spleen in haemostasis. Thromb Haemost 1979; 42: 1529-35.
47. 2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 1991; 100: 1069-77.